|
| | Everolimus Related Compound 3 Basic information |
| Product Name: | Everolimus Related Compound 3 | | Synonyms: | (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-Dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-2-piperidinecarboxylic Acid;Everolimus Impurity 3;Everolimus Related Compound;Everolimus Impurity 013-99;(S)-1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R);2-Piperidinecarboxylic acid, 1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-, (2S)-;(2S)?-1-?[2-?[(2R,?3R,?6S)?-?6-?[(2S,?3E,?5E,?7E,?9S,?11R)?-?2,?13-?Dimethoxy-?3,?9,?11-?trimethyl-?12-?oxo-?3,?5,?7-?tridecatrien-?1-?yl]?tetrahydro-?2-?hydroxy-?3-?methyl-?2H-?pyran-?2-?yl]?-?2-?oxo;(2S)-1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-Dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-2-piperidinecarboxylic Acid | | CAS: | 147438-30-0 | | MF: | C32H49NO9 | | MW: | 591.73 | | EINECS: | | | Product Categories: | | | Mol File: | 147438-30-0.mol |  |
| | Everolimus Related Compound 3 Chemical Properties |
| Boiling point | 734.4±70.0 °C(Predicted) | | density | 1.144±0.06 g/cm3(Predicted) | | pka | 3.24±0.20(Predicted) |
| | Everolimus Related Compound 3 Usage And Synthesis |
| Uses | (2S)?-1-?[2-?[(2R,?3R,?6S)?-?6-?[(2S,?3E,?5E,?7E,?9S,?11R)?-?2,?13-?Dimethoxy-?3,?9,?11-?trimethyl-?12-?oxo-?3,?5,?7-?tridecatrien-?1-?yl]?tetrahydro-?2-?hydroxy-?3-?methyl-?2H-?pyran-?2-?yl]?-?2-?oxoacetyl]?-?2-?piperidinecarboxylic Acid is an impurity of Sirolimus (R124000) which is an immunosuppressant drug used to prevent rejection in organ transplantation. |
| | Everolimus Related Compound 3 Preparation Products And Raw materials |
|
